Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
244
-
Total 13F shares, excl. options
-
40.2M
-
Shares change
-
+486K
-
Total reported value, excl. options
-
$2.38B
-
Value change
-
+$32.8M
-
Put/Call ratio
-
0.83
-
Number of buys
-
130
-
Number of sells
-
-108
-
Price
-
$59.08
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q1 2019
286 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q1 2019.
REPLIGEN CORP - COMMON STOCK (RGEN) has 244 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.2M shares
of 56.2M outstanding shares and own 71.55% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.65M shares), VANGUARD GROUP INC (4.12M shares), WELLINGTON MANAGEMENT GROUP LLP (2.21M shares), Invesco Ltd. (2.02M shares), STATE STREET CORP (1.93M shares), FRED ALGER MANAGEMENT INC (1.64M shares), Conestoga Capital Advisors, LLC (1.64M shares), MACQUARIE GROUP LTD (1.12M shares), OppenheimerFunds, Inc. (1.08M shares), and FEDERATED INVESTORS INC /PA/ (950K shares).
This table shows the top 244 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.